Specific allergen immunotherapy vs no immunotherapy
Investigator‐ or physician‐rated global assessment of disease severity · adults and children with atopic eczema and inhalant allergen sensitisation
It is very uncertain whether specific allergen immunotherapy changes investigator‐ or physician‐rated global assessment of disease severity compared with no immunotherapy (very low certainty).
1 finding from 1 review
- Specific allergen immunotherapy for the treatment of atopic eczema 2016 · Cochrane Headline outcomes onlyRR 1.48 [1.16, 1.88]7 studies · 286 participantsVery low